None listed
Conditions
Brief summary
Follitropin delta is a safe and effective medication to use in ovulation induction prior to intrauterine insemination or frozen embryo transfer with acceptable pregnancy, cycle cancellation, ovarian hyperstimulation syndrome and multiple pregnancy rates. The purpose of the retrospective observational cohort study is to report patient and treatment characteristics and outcome for patients where follitropin delta was used.
Interventions
Patients were prescribed follitropin delta (does was varied and patient dependent) to induce ovulation prior to an intrauterine insemination or frozen embryo transfer. The outcome of the cycle was recorded. Data was collect from day 1 of patients period, at time of ovulation, through till pregnancy test (approx 30 days). Blood samples, scan reports and patient files were reviewed to obtain required information. The Dr notes, patient files and City Fertility and Coastal IVF databases were used
Patients were prescribed follitropin delta (does was varied and patient dependent) to induce ovulation prior to an intrauterine insemination or frozen embryo transfer. The outcome of the cycle was recorded. Data was collect from day 1 of patients period, at time of ovulation, through till pregnancy test (approx 30 days). Blood samples, scan reports and patient files were reviewed to obtain required information. The Dr notes, patient files and City Fertility and Coastal IVF databases were used to obtain patient results. These patients had treatment between 4/5/2020 and 4/3/2025. Collection commenced on day of ethics approval 30/4/25
Sponsors
Ferring
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Any patient that started an intrauterine insemination or frozen embryo transfer cycle using follitropin delta at City Fertility Sydney CBD or Coastal IVF
Exclusion criteria
no exclusion criteria
Outcome results
None listed